John D. Quisel, SVP, Business Development, GC & Secretary at ACCELERON PHARMA INC (XLRN), sold 1,700 shares at $27.56 ($47K) on 2017-01-04, disclosed to the SEC on 2017-01-06.
Scheduled sale ($47k) by SVP, Business Development, GC & Secretary under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $26.43 | 300 | $8K | 17.0% |
| 2 | $27.56 | 1,400 | $39K | 83.0% |
| Total | $27.36 avg | 1,700 | $47K | 100% |
| Filing → |
| IRON | SELL | 2026-06-23 | $2.4M | — | Filing → |
| IRON | SELL | 2026-02-17 | $834K | — | Filing → |
| IRON | SELL | 2025-12-15 | $7.4M | — | Filing → |